IMPROVING IUCD USAGE AMONG REPRODUCTIVE WOMEN WITH DIABETES MELLITUS IN HEALTH CLINICS OF PERLIS
DOI:
https://doi.org/10.63719/qbulletin.v1i28.264Keywords:
IUCD (intrauterine contraceptive device), reproductive diabetic women, contraceptionAbstract
Pregnant women with diabetes mellitus pose an increased risk of maternal and infant morbidity and mortality. In Perlis, for the year of 2016, only 3 (0.3%) out of 1,114 reproductive women with diabetes mellitus were using an intrauterine device (IUCD) as their main contraceptive measure. This project aims to improve the usage of IUCD to 10% among reproductive women with diabetes mellitus in nine health clinics of Perlis.
A retrospective contraception card review was undertaken to determine the baseline in providing IUCD services. Two sets of validated questionnaires were distributed to patients and healthcare providers in the pre and post-remedial period.
Customised training sessions were organised for both doctors and nurses’ group. A quick reference for IUCD was developed to guide the healthcare providers during counselling sessions. The Model of Good Care (MOGC) was integrated into the Maternal and Child Health State Plan of Action 2016 to ease the supervision of quality improvement.
Of the 244 diabetic women who had undergone counselling, 44 (18%) agreed to use IUCD and 38 (16%) of them inserted the IUCD within two weeks. Our project was able to increase the usage of IUCD among diabetic women in nine Perlis health clinics from 3 (0.3%) to 38 (3.4%) within six months. There was a gap reduction in achievable but not achieved (ABNA) from 9.7% to 6.6%. [ABNA = Achievable benefit not achieved]
Low usage of IUCD among diabetic women is a challenging issue and patient refusal to use IUCD, lack of husband support and comfortable with the previous contraception method were among the main contributing factors. However, providing continuous awareness and new process of effort in promoting the usage of IUCD among diabetic women do improve the uptake of the approach.
References
1. Goldstuck ND, Steyn PS. The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review. ISRN Obstet Gynecol. 2013;2013:1–6.
2. World Health Organization. COCs Barrier methods IUDs Fertility awareness-based methods Lactational. Med eligibility criteria Contracept use- 5th ed. 2015;(978 92 4 154915 8).
3. Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: A review. Contraception. 2014;89(3):162–73.
4. Alemayehu M, Belachew T, Tilahun T. Factors associated with utilization of long acting and permanent contraceptive methods among married women of reproductive age in Mekelle town, Tigray region, north Ethiopia. BMC Pregnancy Childbirth. 2012;12(1):6.
5. Kavanaugh ML, Jerman J, Finer LB. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women. 2009;126(5):917–27.


